This page shows MicroAlgo Inc (VENAF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
MicroAlgo Inc has an operating margin of 3.7%, meaning the company retains $4 of operating profit per $100 of revenue. This results in a moderate score of 30/100, indicating healthy but not exceptional operating efficiency. This is up from -42.3% the prior year.
MicroAlgo Inc's revenue declined 8% year-over-year, from $81.9M to $75.3M. This contraction results in a growth score of 20/100.
MicroAlgo Inc carries a low D/E ratio of 0.20, meaning only $0.20 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 6.11, MicroAlgo Inc holds $6.11 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
MicroAlgo Inc has a free cash flow margin of 5.4%, earning a moderate score of 39/100. The company generates positive cash flow after capital investments, but with room for improvement.
MicroAlgo Inc generates a 5.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 22/100. This is up from -82.8% the prior year.
MicroAlgo Inc passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, MicroAlgo Inc generates $0.56 in operating cash flow ($4.1M OCF vs $7.3M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
MicroAlgo Inc earns $0.8 in operating income for every $1 of interest expense ($2.8M vs $3.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
MicroAlgo Inc generated $75.3M in revenue in fiscal year 2024. This represents a decrease of 8.0% from the prior year.
MicroAlgo Inc's EBITDA was $3.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 108.9% from the prior year.
MicroAlgo Inc reported $7.3M in net income in fiscal year 2024. This represents an increase of 119.4% from the prior year.
MicroAlgo Inc earned $0.56 per diluted share (EPS) in fiscal year 2024. This represents an increase of 106.7% from the prior year.
Cash & Balance Sheet
MicroAlgo Inc generated $4.1M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 163.4% from the prior year.
MicroAlgo Inc held $144.1M in cash against $0 in long-term debt as of fiscal year 2024.
Margins & Returns
MicroAlgo Inc's gross margin was 28.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 1.6 percentage points from the prior year.
MicroAlgo Inc's operating margin was 3.7% in fiscal year 2024, reflecting core business profitability. This is up 46.0 percentage points from the prior year.
MicroAlgo Inc's net profit margin was 9.7% in fiscal year 2024, showing the share of revenue converted to profit. This is up 55.6 percentage points from the prior year.
MicroAlgo Inc's ROE was 5.0% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 87.9 percentage points from the prior year.
Capital Allocation
MicroAlgo Inc invested $15.5M in research and development in fiscal year 2024. This represents a decrease of 31.7% from the prior year.
MicroAlgo Inc invested $4K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 60.9% from the prior year.
VENAF Income Statement
| Metric | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | $17.8M | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | $12.9M | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | $5.0M | N/A | $433K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | $5.2M | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | $1.0M | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | -$1.4M | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | $4K | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | $5K | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | -$1.3M | N/A | $433K |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
VENAF Balance Sheet
| Metric | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $330.8M+87.7% | $176.3M+63.8% | $107.6M+85.6% | $58.0M-19.3% | $71.8M-5.1% | $75.6M+4.9% | $72.1M+49.7% | $48.2M |
| Current Assets | $330.5M+87.9% | $175.9M+63.9% | $107.3M+86.2% | $57.6M+3.2% | $55.9M-4.9% | $58.7M+6.4% | $55.2M+166634.1% | $33K |
| Cash & Equivalents | $253.3M+75.8% | $144.1M+137.0% | $60.8M+35.8% | $44.8M+133.4% | $19.2M-8.6% | $21.0M-50.9% | $42.7M+234280.3% | $18K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | $131K | N/A |
| Accounts Receivable | $3.3M-0.4% | $3.3M+9.0% | $3.0M-6.8% | $3.2M-37.8% | $5.2M+216.5% | $1.6M-36.6% | $2.6M | N/A |
| Goodwill | N/A | N/A | N/A | N/A | $14.7M-4.9% | $15.5M+1.4% | $15.3M | N/A |
| Total Liabilities | $10.1M-65.2% | $28.9M-4.5% | $30.3M+151.2% | $12.0M+1.5% | $11.9M+36.0% | $8.7M+71.8% | $5.1M-90.1% | $51.5M |
| Current Liabilities | $10.0M-65.3% | $28.8M-4.7% | $30.2M+150.7% | $12.0M+3.8% | $11.6M+38.0% | $8.4M+75.2% | $4.8M+119.4% | $2.2M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $317.6M+119.1% | $144.9M+90.8% | $76.0M+67.4% | $45.4M-24.9% | $60.4M-9.4% | $66.7M-0.1% | $66.8M+2113.1% | -$3.3M |
| Retained Earnings | -$992K+78.8% | -$4.7M+45.3% | -$8.5M+21.6% | -$10.9M-175.5% | $14.4M-19.4% | $17.9M-6.6% | $19.1M+661.5% | -$3.4M |
VENAF Cash Flow Statement
| Metric | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | -$3.8M-38.5% | -$2.8M-218.6% | $2.3M+2917.8% | -$83K |
| Capital Expenditures | N/A | N/A | N/A | N/A | $11.5M+21011.8% | $54K | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | -$15.3M-444.2% | -$2.8M | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | $481K+287.3% | -$257K-106.2% | $4.1M | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | $1.8M+109.1% | -$19.6M-371.1% | -$4.2M-383.2% | $1.5M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
VENAF Financial Ratios
| Metric | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | 27.8% | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | -7.9% | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | -7.1% | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | -1.9% | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | -1.7% | N/A | 0.9% |
| Current Ratio | 33.05+26.9 | 6.11+2.6 | 3.55-1.2 | 4.79-0.0 | 4.81-2.2 | 6.98-4.5 | 11.49+11.5 | 0.02 |
| Debt-to-Equity | 0.03-0.2 | 0.20-0.2 | 0.40+0.1 | 0.27+0.1 | 0.20+0.1 | 0.13+0.1 | 0.08+15.6 | -15.53 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | -15.8% | N/A | N/A |
Frequently Asked Questions
What is MicroAlgo Inc's annual revenue?
MicroAlgo Inc (VENAF) reported $75.3M in total revenue for fiscal year 2024. This represents a -8.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is MicroAlgo Inc's revenue growing?
MicroAlgo Inc (VENAF) revenue declined by 8% year-over-year, from $81.9M to $75.3M in fiscal year 2024.
Is MicroAlgo Inc profitable?
Yes, MicroAlgo Inc (VENAF) reported a net income of $7.3M in fiscal year 2024, with a net profit margin of 9.7%.
What is MicroAlgo Inc's EBITDA?
MicroAlgo Inc (VENAF) had EBITDA of $3.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is MicroAlgo Inc's gross margin?
MicroAlgo Inc (VENAF) had a gross margin of 28.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is MicroAlgo Inc's operating margin?
MicroAlgo Inc (VENAF) had an operating margin of 3.7% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is MicroAlgo Inc's net profit margin?
MicroAlgo Inc (VENAF) had a net profit margin of 9.7% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is MicroAlgo Inc's return on equity (ROE)?
MicroAlgo Inc (VENAF) has a return on equity of 5.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is MicroAlgo Inc's free cash flow?
MicroAlgo Inc (VENAF) generated $4.1M in free cash flow during fiscal year 2024. This represents a 163.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is MicroAlgo Inc's operating cash flow?
MicroAlgo Inc (VENAF) generated $4.1M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are MicroAlgo Inc's total assets?
MicroAlgo Inc (VENAF) had $176.3M in total assets as of fiscal year 2024, including both current and long-term assets.
What are MicroAlgo Inc's capital expenditures?
MicroAlgo Inc (VENAF) invested $4K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does MicroAlgo Inc spend on research and development?
MicroAlgo Inc (VENAF) invested $15.5M in research and development during fiscal year 2024.
What is MicroAlgo Inc's current ratio?
MicroAlgo Inc (VENAF) had a current ratio of 6.11 as of fiscal year 2024, which is generally considered healthy.
What is MicroAlgo Inc's debt-to-equity ratio?
MicroAlgo Inc (VENAF) had a debt-to-equity ratio of 0.20 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is MicroAlgo Inc's return on assets (ROA)?
MicroAlgo Inc (VENAF) had a return on assets of 4.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is MicroAlgo Inc's Piotroski F-Score?
MicroAlgo Inc (VENAF) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are MicroAlgo Inc's earnings high quality?
MicroAlgo Inc (VENAF) has an earnings quality ratio of 0.56x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can MicroAlgo Inc cover its interest payments?
MicroAlgo Inc (VENAF) has an interest coverage ratio of 0.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is MicroAlgo Inc?
MicroAlgo Inc (VENAF) scores 52 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.